New Rx for Bipolar Disorder
The US Food and Drug Administration (FDA) has approved a new treatment for bipolar disorder.
First Digital Medication Approved
Abilify MyCite is the first digital medication system approved by the US Food and Drug Administration (FDA).
First Tardive Dyskinesia Rx Approved
The US Food and Drug Administration (FDA) has approved the first drug to treat tardive dyskinesia.
Blood Pressure Medications and Mental Health
What do blood pressure medications have to do with mood disorders? According to new research, there may be a link.
From Bipolar Disorder to Substance Use
Now there's more evidence to support a link between bipolar disorder and substance use disorder in adolescents, according to a new study.
A New Warning for Olanzapine
The US Food and Drug Administration (FDA) is warning about the possibility for a rare but serious skin reaction from a particular antipsychotic.
New Warning For Aripiprazole
The US Food and Drug Administration (FDA) is warning about possible impulse-control problems, such as compulsive or uncontrollable urges, tied to a particular antipsychotic.
Undiagnosed Bipolar: The New Findings
If you have depression or anxiety, new evidence suggests you may actually be suffering from something else.
What Omega-3s Could Do for Bipolar Patients
Omega-3s are often praised for their heart health benefits. But new evidence suggests the fatty acids may play an important role in mental health, too.
The Expiration Date for Antipsychotic Benefits
After an acute manic episode, bipolar patients are often kept on antipsychotic medications to prevent future episodes. But the potential risks of this practice may outweigh the benefits.